Yan Meng
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ 7
- Genetics top 10%
- Cancer Research top 10%
-
- Immune Response and Inflammation 5
- Immune Cell Function and Interaction 3
-
- PI3K/AKT/mTOR signaling in cancer 3
-
- Liver Disease and Transplantation 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Enzyme-mediated dye degradation 2
-
- Microbial Natural Products and Biosynthesis 2
- Cited by
- Cell BiologyGeneticsCancer Research
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Yan Meng
39 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 103
- Cell Biology 205
- Genetics 128
- Cancer Research 176
- Immunology 216
- Molecular Biology 584
Countries citing papers authored by Yan Meng
This map shows the geographic impact of Yan Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Meng more than expected).
Fields of papers citing papers by Yan Meng
This network shows the impact of papers produced by Yan Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Meng. The network helps show where Yan Meng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yan Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 15 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 74 | |
| 9 | 2021 | 32 | |
| 10 | 2020 | 80 | |
| 11 | 2020 | 93 | |
| 12 | 2020 | 17 | |
| 13 | 2019 | 17 | |
| 14 | 2019 | 7 | |
| 15 | 2018 | 62 | |
| 16 | 2017 | 90 | |
| 17 | 2017 | 21 | |
| 18 | 2016 | 89 | |
| 19 | 2013 | 77 | |
| 20 | 2011 | 10 |
About Yan Meng
Yan Meng is a scholar working on Cancer Research, Hepatology and Cell Biology, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (7 papers), Immune Response and Inflammation (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Liver Disease and Transplantation (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Immune Cell Function and Interaction (3 papers), Enzyme-mediated dye degradation (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Cell Biology (205 citations), Genetics (128 citations) and Cancer Research (176 citations). Yan Meng has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Zhifeng Gu, Ding Ai, Yi Zhu, Chun Cheng, Wei Tan, Xiaoming Deng, Chunjiong Wang, Jinjun Bian, Jinlong He and Guijuan Feng.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.